HOME >> MEDICINE >> NEWS
FDA grants accelerated approval of TYSABRI, formerly antegren, for the treatment of MS

Phase III trials at one year demonstrate new level of efficacy 66% reduction in rate of relapses seen in AFFIRM monotherapy trial

Cambridge, MA; San Diego, CA; Dublin, Ireland November 23, 2004 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the U.S. Food and Drug Administration (FDA) has approved TYSABRI (natalizumab), formerly referred to as ANTEGREN, as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses. FDA granted Accelerated Approval for TYSABRI following Priority Review based on one-year data from two Phase III studies, the AFFIRM monotherapy trial and the SENTINEL add-on trial with AVONEX(Interferon beta-1a).

TYSABRI, the first humanized monoclonal antibody approved for the treatment of MS, inhibits adhesion molecules on the surface of immune cells. Research suggests TYSABRI works by preventing immune cells from migrating from the bloodstream into the brain where they can cause inflammation and potentially damage nerve fibers and their insulation.

"TYSABRI is a powerful and innovative therapy that offers new hope for hundreds of thousands of people living with MS," said James C. Mullen, chief executive officer, Biogen Idec. "We believe TYSABRI will revolutionize the treatment of MS and become the leading choice for patients and physicians."

"TYSABRI is a significant breakthrough for patients with MS," said Kelly Martin, president and chief executive officer, Elan. "The approval of TYSABRI, with its unique mechanism of action and new level of efficacy, has the potential to make a genuine difference in the lives of patients and families who struggle with the debilitating effects of this disease."

Results of the AFFIRM Monotherapy Trial

AFFIRM is a two-year, randomized, multi-center, placebo-controlled, double-blind study of 942 patients conducted in 99 sites worldwide, in which patients were
'"/>

Contact: Amy Losak
646-935-9317
Ketchum
23-Nov-2004


Page: 1 2 3 4 5 6

Related medicine news :

1. UNH launches 2nd spinout company with NIH grants
2. Disease testing for immigrants: Discrimination disguised as public health policy
3. US FDA grants full approval to DOXIL(R) following submission of phase III data
4. Four teams awarded inaugural translational cancer research grants
5. Immigrants, beware: Living in the United States is fattening
6. Prevalence of obesity among immigrants increases with longer residency in US
7. Dana-Farber receives CDC grants to develop health promotion/prevention programs in the work place
8. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants
9. Should compulsory screening of immigrants be part of UK public health policy?
10. NIH grants support health disparities biomedical research
11. NCCAM awards planning grants for International Centers for Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... The ... be held Wednesday, April 7, to Saturday, April 10, 2021, at Wynn Las ... Show is a national trade show for non-invasive medical aesthetic practices that brings ...
(Date:9/2/2020)... FORT WASHINGTON, Pa. (PRWEB) , ... September 02, ... ... the development of enterprise software for healthcare payers administering Medicare Advantage and Special ... and Duals Online presented by America’s Health Insurance Plans (AHIP). RAM is supporting ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... Feeding ... care for children with Pediatric Feeding Disorder (PFD), is pleased to announce that the ... a stand-alone diagnostic code (R code) in the next edition of the U.S. ...
(Date:8/31/2020)... PITTSBURGH (PRWEB) , ... August 31, 2020 , ... ... Allegheny Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) ... alternative for cardiac patients who have undergone open heart surgery. , The AGH/CMU ...
(Date:8/31/2020)... ... 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical distributor Gulf ... responders across the United States. Since the start of the global COVID-19 pandemic, ... medical centers , hospitals , firefighters , and public schools ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... Sanitizing and Disinfecting - a broad-spectrum sanitization, disinfection and deodorization provider - ... will offer door-to-door sanitizing and disinfecting services for businesses and residents throughout the ...
(Date:8/28/2020)... ... August 28, 2020 , ... Cano Health, LLC, ... in Florida and San Antonio is happy to announce that it has selected ... In this capacity he will serve as community advisor, advertising talent, and creative ...
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Raheleh ... a unique perspective and approach. Armed with her qualifications from Ross University School ... her knowledge of the human body with the nation and world. With a ...
Breaking Medicine Technology:
Cached News: